Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Cost of illness in patients with multiple myeloma in Italy: the CoMiM study.

Petrucci MT, Calabrese E, Levi A, Federico V, Ceccolini M, Rizzi R, Gozzetti A, Falco P, Lazzaro C, Martelli E, Boccadoro M, Lauria F, Liso V, Cavo M, Foa R.

Tumori. 2013 Jul-Aug;99(4):e193-202. doi: 10.1700/1361.15125.

PMID:
24326862
2.

Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.

Bazarbachi A, Labopin M, Ghavamzadeh A, Giebel S, Al-Zahrani H, Ladeb S, Leone G, Abdel-Rahman F, Liso V, Hamidieh AA, Rasheed W, Ibrahim A, Alabdulaaly A, Kyrcz-Krzemien S, Arnold R, Kharfan-Dabaja MA, Alimoghaddam K, Aljurf M, Mohty M.

Bone Marrow Transplant. 2013 Aug;48(8):1065-9. doi: 10.1038/bmt.2013.1. Epub 2013 Jan 28.

PMID:
23353802
3.

Myeloma cells suppress osteoblasts through sclerostin secretion.

Colucci S, Brunetti G, Oranger A, Mori G, Sardone F, Specchia G, Rinaldi E, Curci P, Liso V, Passeri G, Zallone A, Rizzi R, Grano M.

Blood Cancer J. 2011 Jun;1(6):e27. doi: 10.1038/bcj.2011.22. Epub 2011 Jun 24.

4.

Quality of life and physicians' perception in myelodysplastic syndromes.

Oliva EN, Finelli C, Santini V, Poloni A, Liso V, Cilloni D, Impera S, Terenzi A, Levis A, Cortelezzi A, Ghio R, Musto P, Semenzato G, Clissa C, Lunghi T, Trappolini S, Gaidano V, Salvi F, Reda G, Villani O, Binotto G, Cufari P, Cavalieri E, Spiriti MA.

Am J Blood Res. 2012;2(2):136-47. Epub 2012 May 25.

5.

SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.

Mauro FR, Bandini G, Barosi G, Billio A, Brugiatelli M, Cuneo A, Lauria F, Liso V, Marchetti M, Meloni G, Montillo M, Zinzani P, Tura S; Italian Society of Hematology; Società Italiana di Ematologia Sperimentale; Gruppo Italiano Trapianto di Midollo Osseo.

Leuk Res. 2012 Apr;36(4):459-66. doi: 10.1016/j.leukres.2011.08.013. Epub 2011 Sep 1.

PMID:
21885123
6.

A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome.

Rizzi R, Miccolis R, Rinaldi E, Bonerba B, Rossini M, Manno C, Curci P, Specchia G, Liso V.

Amyloid. 2011 Jun;18 Suppl 1:117-8. doi: 10.3109/13506129.2011.574354043. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:118.

PMID:
21838455
7.

TRAIL effect on osteoclast formation in physiological and pathological conditions.

Brunetti G, Oranger A, Mori G, Sardone F, Pignataro P, Coricciati M, Napoli N, Rizzi R, Liso V, Grassi FR, Grano M, Colucci S.

Front Biosci (Elite Ed). 2011 Jun 1;3:1154-61.

PMID:
21622121
8.

High Ki67 index and bulky disease remain significant adverse prognostic factors in patients with diffuse large B cell lymphoma before and after the introduction of rituximab.

Gaudio F, Giordano A, Perrone T, Pastore D, Curci P, Delia M, Napoli A, de' Risi C, Spina A, Ricco R, Liso V, Specchia G.

Acta Haematol. 2011;126(1):44-51. doi: 10.1159/000324206. Epub 2011 Mar 24.

PMID:
21430371
9.

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

Gaudio F, Giordano A, Pavone V, Perrone T, Curci P, Pastore D, Delia M, De' Risi C, Spina A, Liso V, Specchia G.

Adv Hematol. 2011;2011:707542. doi: 10.1155/2011/707542. Epub 2010 Dec 29.

10.

Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.

Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M, Liso V, Cuneo A, Foà R.

Haematologica. 2011 Feb;96(2):277-83. doi: 10.3324/haematol.2010.030189. Epub 2010 Oct 22.

11.

Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.

Albano F, Anelli L, Zagaria A, Coccaro N, Casieri P, Rossi AR, Vicari L, Liso V, Rocchi M, Specchia G.

Mol Cancer. 2010 May 25;9:120. doi: 10.1186/1476-4598-9-120.

12.

Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation.

Pastore D, Delia M, Mestice A, Perrone T, Carluccio P, Gaudio F, Giordano A, Rossi AR, Ricco A, Leo M, Liso V, Specchia G.

Biol Blood Marrow Transplant. 2011 Apr;17(4):550-7. doi: 10.1016/j.bbmt.2010.04.011. Epub 2010 May 10.

13.

The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of soluble decoy receptor 3.

Brunetti G, Oranger A, Mori G, Centonze M, Colaianni G, Rizzi R, Liso V, Zallone A, Grano M, Colucci S.

Ann N Y Acad Sci. 2010 Mar;1192:298-302. doi: 10.1111/j.1749-6632.2009.05304.x.

PMID:
20392250
14.

Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia.

Albano F, Anelli L, Zagaria A, Coccaro N, D'Addabbo P, Liso V, Rocchi M, Specchia G.

Oncogene. 2010 Apr 29;29(17):2509-16. doi: 10.1038/onc.2009.524. Epub 2010 Jan 25.

PMID:
20101201
15.

The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.

Molica S, Mauro FR, Callea V, Giannarelli D, Lauria F, Rotoli B, Cortelezzi A, Liso V, Foà R.

Haematologica. 2010 Mar;95(3):464-9. doi: 10.3324/haematol.2009.011767. Epub 2009 Nov 10.

16.

Amyloid in bone marrow smears of patients affected by multiple myeloma.

Petruzziello F, Zeppa P, Catalano L, Cozzolino I, Gargiulo G, Musto P, D'Auria F, Liso V, Rizzi R, Caruso N, Califano C, Piro E, Musso M, Bonanno V, Pia Falcone A, Tafuto S, Di Raimondo F, De Laurentiis M, Pane F, Palombini L, Rotoli B.

Ann Hematol. 2010 May;89(5):469-74. doi: 10.1007/s00277-009-0857-9. Epub 2009 Nov 6.

PMID:
19894050
17.

Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.

Mandelli F, Vignetti M, Suciu S, Stasi R, Petti MC, Meloni G, Muus P, Marmont F, Marie JP, Labar B, Thomas X, Di Raimondo F, Willemze R, Liso V, Ferrara F, Baila L, Fazi P, Zittoun R, Amadori S, de Witte T.

J Clin Oncol. 2009 Nov 10;27(32):5397-403. doi: 10.1200/JCO.2008.20.6490. Epub 2009 Oct 13. Erratum in: J Clin Oncol. 2010 Mar 10;28(8):1438.

18.

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

Voso MT, Santini V, Finelli C, Musto P, Pogliani E, Angelucci E, Fioritoni G, Alimena G, Maurillo L, Cortelezzi A, Buccisano F, Gobbi M, Borin L, Di Tucci A, Zini G, Petti MC, Martinelli G, Fabiani E, Fazi P, Vignetti M, Piciocchi A, Liso V, Amadori S, Leone G.

Clin Cancer Res. 2009 Aug 1;15(15):5002-7. doi: 10.1158/1078-0432.CCR-09-0494. Epub 2009 Jul 28.

19.

Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients.

Colucci S, Brunetti G, Mori G, Oranger A, Centonze M, Mori C, Cantatore FP, Tamma R, Rizzi R, Liso V, Zallone A, Grano M.

Leukemia. 2009 Nov;23(11):2139-46. doi: 10.1038/leu.2009.136. Epub 2009 Jul 9.

PMID:
19587706
20.

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.

Guglielmelli P, Barosi G, Specchia G, Rambaldi A, Lo Coco F, Antonioli E, Pieri L, Pancrazzi A, Ponziani V, Delaini F, Longo G, Ammatuna E, Liso V, Bosi A, Barbui T, Vannucchi AM.

Blood. 2009 Aug 20;114(8):1477-83. doi: 10.1182/blood-2009-04-216044. Epub 2009 Jun 23.

21.

MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9).

Albano F, Anelli L, Zagaria A, Liso V, Rocchi M, Specchia G.

Br J Haematol. 2009 Jan;144(2):271-3. doi: 10.1111/j.1365-2141.2008.07459.x. Epub 2008 Nov 19. No abstract available.

PMID:
19036106
22.

Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9).

Albano F, Anelli L, Zagaria A, Pannunzio A, Liso V, Rocchi M, Specchia G.

Leukemia. 2009 Apr;23(4):813-6. doi: 10.1038/leu.2008.311. Epub 2008 Nov 6. No abstract available.

PMID:
18987658
23.

Consensus conference on the management of tumor lysis syndrome.

Tosi P, Barosi G, Lazzaro C, Liso V, Marchetti M, Morra E, Pession A, Rosti G, Santoro A, Zinzani PL, Tura S.

Haematologica. 2008 Dec;93(12):1877-85. doi: 10.3324/haematol.13290. Epub 2008 Oct 6.

24.

Schnitzler's syndrome: monoclonal gammopathy associated with chronic urticaria.

Rizzi R, Curci P, Rinaldi E, Rinaldi F, Cimmino A, Ricco R, Specchia G, Liso V.

Acta Haematol. 2008;120(1):1-4. doi: 10.1159/000143499. Epub 2008 Jul 9.

PMID:
18612198
25.

The double deceit generated by an insertion mechanism in chronic myeloid leukemia with t(9;9;22).

Albano F, Zagaria A, Anelli L, Pannunzio A, Manodoro F, Coccaro N, Russo Rossi A, Liso V, Rocchi M, Specchia G.

Ann Hematol. 2008 Nov;87(11):923-6. doi: 10.1007/s00277-008-0511-y. Epub 2008 Jun 14. No abstract available.

PMID:
18553081
26.

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.

Vannucchi AM, Antonioli E, Guglielmelli P, Pancrazzi A, Guerini V, Barosi G, Ruggeri M, Specchia G, Lo-Coco F, Delaini F, Villani L, Finotto S, Ammatuna E, Alterini R, Carrai V, Capaccioli G, Di Lollo S, Liso V, Rambaldi A, Bosi A, Barbui T.

Blood. 2008 Aug 1;112(3):844-7. doi: 10.1182/blood-2008-01-135897. Epub 2008 Jun 2.

27.

M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience.

Pulsoni A, Iacobelli S, Bernardi M, Borgia M, Camera A, Cantore N, Di Raimondo F, Fazi P, Ferrara F, Leoni F, Liso V, Mancini M, Marmont F, Matturro A, Maurillo L, Melillo L, Meloni G, Mirto S, Specchia G, Valentini CG, Venditti A, Leone G, Foà R, Mandelli F, Pagano L.

Haematologica. 2008 Jul;93(7):1025-32. doi: 10.3324/haematol.11889. Epub 2008 May 27.

28.

Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.

Rizzi R, Curci P, Delia M, Rinaldi E, Chiefa A, Specchia G, Liso V.

Med Oncol. 2009;26(1):1-9. doi: 10.1007/s12032-008-9069-8. Epub 2008 May 7. Review.

PMID:
18461290
29.

Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML.

Pastore D, Mestice A, Perrone T, Gaudio F, Delia M, Albano F, Russo Rossi A, Carluiccio P, Leo M, Liso V, Specchia G.

Bone Marrow Transplant. 2008 Jun;41(11):977-81. doi: 10.1038/bmt.2008.87. Epub 2008 Apr 21.

PMID:
18425147
30.

Genomic and molecular switching in relapsed acute promyelocytic leukemia.

Albano F, Pannunzio A, Anelli L, Zagaria A, Liso V, Rocchi M, Specchia G.

Leukemia. 2008 Jul;22(7):1469-72. doi: 10.1038/sj.leu.2405103. Epub 2008 Feb 7. No abstract available.

PMID:
18256686
31.

Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisation.

Dettori S, Argentini C, Marcucci F, Spada E, Chionne P, Candido A, Madonna E, Ciccaglione AR, Bianco E, Iannitto E, Musto P, Liso V, De Renzo A, Pagano L, Nieddu G, Pulsoni A, Mele A, Rapicetta M.

New Microbiol. 2007 Jul;30(3):265-70.

32.

Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia.

Albano F, Anelli L, Zagaria A, Lonoce A, La Starza R, Liso V, Rocchi M, Specchia G.

Leuk Res. 2008 Feb;32(2):347-51. Epub 2007 Aug 2.

PMID:
17681599
33.

Primary intracranial dural B cell small lymphocytic lymphoma.

Giordano A, Perrone T, Guarini A, Ciappetta P, Rubini G, Ricco R, Palma M, Specchia G, Liso V.

Leuk Lymphoma. 2007 Jul;48(7):1437-43. Review. No abstract available.

PMID:
17613779
34.
35.
36.

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, Marfisi RM, Finazzi G, Guerini V, Fabris F, Randi ML, De Stefano V, Caberlon S, Tafuri A, Ruggeri M, Specchia G, Liso V, Rossi E, Pogliani E, Gugliotta L, Bosi A, Barbui T.

Blood. 2007 Aug 1;110(3):840-6. Epub 2007 Mar 22.

37.

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.

Specchia G, Pastore D, Carluccio P, Spinosa G, Giannoccaro M, Rizzi R, Mestice A, Liso V.

Ann Hematol. 2007 Jun;86(6):425-8. Epub 2007 Mar 16.

PMID:
17364181
38.

Common variable immunodeficiency patient with large granular lymphocytosis developing extranodal diffuse large B-cell lymphoma: a case report.

Delia M, Liso V, Capalbo S, Napoli A, Ricco R, Semenzato G, Liso A.

Haematologica. 2006 Dec;91(12 Suppl):ECR61.

39.

Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia.

Barcellini W, Capalbo S, Agostinelli RM, Mauro FR, Ambrosetti A, Calori R, Cortelezzi A, Laurenti L, Pogliani EM, Pedotti P, Liso V, Girelli G, Mandelli F, Zanella A; GIMEMA Chronic Lymphocytic Leukemia Group.

Haematologica. 2006 Dec;91(12):1689-92.

40.

Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

Brugiatelli M, Bandini G, Barosi G, Lauria F, Liso V, Marchetti M, Mauro FR, Meloni G, Zinzani PL, Tura S; Italian Society of Hematology; Italian Society of Experimental Hematology; Italian Group for Bone Marrow Transplantation.

Haematologica. 2006 Dec;91(12):1662-73.

41.

Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients.

Specchia G, Pastore D, Mestice A, Liso A, Carluccio P, Leo M, Casanova M, Sibilla S, Giannoccaro M, Liso V.

Acta Haematol. 2006;116(4):229-37.

PMID:
17119322
42.

The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease.

Brunetti G, Colucci S, Rizzi R, Mori G, Colaianni G, Oranger A, Zallone A, Liso V, Grano M.

Ann N Y Acad Sci. 2006 Apr;1068:334-40.

PMID:
16831934
43.

Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients.

Capalbo S, Delia M, Diomede D, Dargenio M, Chiefa A, Favia G, Liso V.

Int J Hematol. 2006 Jun;83(5):439-42.

PMID:
16787865
44.

Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.

Zagaria A, Anelli L, Albano F, Vicari L, Schiavone EM, Annunziata M, Pane F, Liso V, Rocchi M, Specchia G.

Cancer Genet Cytogenet. 2006 Jun;167(2):97-102.

PMID:
16737907
45.

Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.

Trubia M, Albano F, Cavazzini F, Cambrin GR, Quarta G, Fabbiano F, Ciambelli F, Magro D, Hernandezo JM, Mancini M, Diverio D, Pelicci PG, Coco FL, Mecucci C, Specchia G, Rocchi M, Liso V, Castoldi G, Cuneo A.

Leukemia. 2006 Jan;20(1):48-54.

PMID:
16619048
46.

High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma.

Marcucci F, Mele A, Spada E, Candido A, Bianco E, Pulsoni A, Chionne P, Madonna E, Cotichini R, Barbui A, De Renzo A, Dore F, Iannitto E, Liso V, Martino B, Montanaro M, Pagano L, Musto P, Rapicetta M.

Haematologica. 2006 Apr;91(4):554-7.

47.

The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.

Albano F, Mestice A, Pannunzio A, Lanza F, Martino B, Pastore D, Ferrara F, Carluccio P, Nobile F, Castoldi G, Liso V, Specchia G.

Haematologica. 2006 Mar;91(3):311-6.

48.

Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation.

Pavone V, Gaudio F, Console G, Vitolo U, Iacopino P, Guarini A, Liso V, Perrone T, Liso A.

Bone Marrow Transplant. 2006 Apr;37(8):719-24.

PMID:
16518434
49.

Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia.

Albano F, Specchia G, Anelli L, Zagaria A, Archidiacono N, Liso V, Rocchi M.

Ann Hematol. 2006 Feb;85(2):129-31. Epub 2005 Oct 19. No abstract available.

PMID:
16235079
50.

FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.

Specchia G, Pastore D, Carluccio P, Liso A, Mestice A, Rizzi R, Ciuffreda L, Pietrantuono G, Liso V.

Ann Hematol. 2005 Nov;84(12):792-5. Epub 2005 Nov 12.

PMID:
16047203

Supplemental Content

Support Center